As a result, there is an increasing need for highly trained professionals who can provide expert analysis and research in health economics, including patient reported outcomes, economic modeling methodologies, and epidemiology. This need extends across the pharmaceutical industry, among healthcare providers, private payers, and within government agencies.
This new Health Outcomes, Policy and Economics program from Rutgers University responds to industry needs and increased demand for trained professionals to conduct research in health economics/outcomes, cost effectiveness, and health policy. Its interdisciplinary curriculum draws on considerable expertise at Rutgers University in economics, data analysis, biostatistics, health policy, and clinical research, and emphasizes the role of pharmaceuticals in the provision of health care. Graduates will have an integrated and comprehensive grounding in health outcomes research, epidemiology, health policy and practice in healthcare.
Upon graduation, a student completing the MS curriculum in Health Outcomes, Policy, and Economics will be able to:
- Design, evaluate, interpret, and communicate the results of non-randomized, observational research for applications in health outcomes, health economics, and health policy research
- Evaluate the reliability, validity, and generalizability of individual biomedical research studies
- Synthesize evidence for health policy decision makers to facilitate translation of interventions, applications, or programs
- Use statistical and business software to analyze health outcomes, health care costs, health policy, and health economics
- Work independently and as part of a team to conduct health outcomes and economics research (HEOR) projects
- Health Systems & Policy
- Introduction to Biostatistics
- Principles & Methods of Epidemiology
- Health Care Economics
- Intermediate Epidemiologic Research Methods
- Regression Methods for Public Health Studies
- Introduction to Outcomes Research
- Legal, Regulatory, and Ethical Issues in the Pharmaceutical Industry
- Public Health, Ethics & Law
- Applied Methods in Epidemiologic Research
- Clinical Trials: Design & Analysis of Medical Experiments
- Cost-effectiveness in Public Health and Medicine
- Evidence Based Literature Review
- Pharmacoepidemiology and Therapeutic Risk Management
- Topics in Comparative Effectiveness
- 12 months
Start dates & application deadlines
- StartingApplication deadline not specified.
DisciplinesEconomics Health Management View 417 other Masters in Health Management in United States
- Required from an accredited school in the US or Canada; GPA of 3.0 or higher; for applicants with a professional degree see “waivers for undergraduate degree transcript”
- General Exam. Use GRE code 2567 to forward your GRE standardized test scores to the Rutgers School of Public Health (New Brunswick campus)
- Two letters are required for Master's degree applicants.
International17766 USD/yearTuition FeeBased on the original amount of 17766 USD per year and a duration of 12 months.
National17766 USD/yearTuition FeeBased on the original amount of 17766 USD per year and a duration of 12 months.
In-State9029 USD/yearTuition FeeBased on the original amount of 9029 USD per year and a duration of 12 months.
Studyportals Tip: Students can search online for independent or external scholarships that can help fund their studies. Check the scholarships to see whether you are eligible to apply. Many scholarships are either merit-based or needs-based.